Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials

scientific article

Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1016761802
P356DOI10.1186/1471-2407-12-526
P932PMC publication ID3551633
P698PubMed publication ID23153379
P5875ResearchGate publication ID233422570

P2093author name stringPeng Gao
Yingying Xu
Huimian Xu
Zhenning Wang
Yongxi Song
Jingxu Sun
Xiaowan Chen
Jiwang Liang
P2860cites workGlobal cancer statistics, 2002Q27860562
Measuring inconsistency in meta-analysesQ27860655
Assessing the quality of reports of randomized clinical trials: is blinding necessary?Q27860973
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junctionQ28215716
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancerQ29619394
Epidemiology of gastric cancerQ33788193
Clinical delivery system for intraperitoneal hyperthermic chemotherapy.Q34268781
Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancerQ35597399
Meta-analysis of intraperitoneal chemotherapy for gastric cancerQ35862307
A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer.Q36892244
Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled studyQ39013638
Recent patterns in gastric cancer: a global overviewQ39985871
Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosisQ41741362
A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP).Q43798130
Postoperative intraperitioneal hyperthermic chemoperfusion combined with intravenous chemotherapy for 82 advanced gastric cancer patientsQ45019061
Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma.Q51468726
Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study.Q51636076
Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin CQ70369682
Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasionQ70783122
Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in ratsQ71507553
The surgical treatment of cancer of the stomachQ72624999
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective studyQ73368601
Use of nitrogen mustard in treatment of serous effusions of neoplastic originQ73851004
Prospective study of peritoneal recurrence after curative surgery for gastric cancerQ73876936
Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled studyQ77553200
Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression analysisQ78168251
Selective destruction of cancers after exposure to heatQ79372430
[Application of hyperthermic intraoperative intraperitoneal chemotherapy in patients with gastric cancer]Q80691240
[Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer]Q81631874
[Clinical application of perioperative continuous hyperthermic peritoneal perfusion chemotherapy for gastric cancer]Q83397739
Gastric cancerQ84276928
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
chemotherapyQ974135
meta-analysisQ815382
P304page(s)526
P577publication date2012-11-16
P1433published inBMC CancerQ326300
P1476titleBenefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials
P478volume12

Reverse relations

cites work (P2860)
Q35898235A Comparison of Intravenous plus Intraperitoneal Chemotherapy with Intravenous Chemotherapy Alone for the Treatment of Gastric Cancer: A Meta-Analysis
Q37108203A retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
Q28088619Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review
Q26774528Advanced gastric cancer: What we know and what we still have to learn
Q90609239Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy
Q58768727Comparative effectiveness of hyperthermic intraperitoneal chemotherapy for gastric cancer: A systematic review and network meta-analysis protocol
Q36160064Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details
Q26774538Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer
Q39642640Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion for the treatment of gastric cancer: A single-centre retrospective study
Q38931710Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence
Q92713103Implications of clinical research on adjuvant chemotherapy for gastric cancer: Where to go next?
Q89953619Intraperitoneal chemotherapy for locally advanced gastric cancer to prevent and treat peritoneal carcinomatosis
Q38156120Intraperitoneal chemotherapy: rationale, applications, and limitations
Q91910752Issues on peritoneal metastasis of gastric cancer: an update
Q64235347Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures
Q33895603Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis
Q58766340Peritoneal carcinomatosis
Q34366940Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?
Q53116372Phase II Trial of Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Carcinomatosis or Positive Peritoneal Cytology in Patients with Gastric Adenocarcinoma.
Q36758901Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Q90165865Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study
Q90749102Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer-A Systematic Review
Q39674083Prophylactic hyperthermic intraperitoneal chemotherapy can be considered in the management of advanced gastric cancer
Q36758921The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.
Q58751021The incidence and risk factors of hepatotoxicity induced by perioperative hyperthermic intraperitoneal chemotherapy in gastrointestinal carcinoma patients: a retrospective study
Q38201470The treatment of peritoneal carcinomatosis in advanced gastric cancer: state of the art.
Q33621706The value of staging laparoscopy in gastric cancer
Q34137285Towards personalized perioperative treatment for advanced gastric cancer.
Q26744031Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives